#21 · Structural bio & protein design
Learned models predict ADMET endpoints and prioritize synthesizable small molecules
The dominant thread is learned models over small-molecule representations for property prediction and candidate prioritization. Three preprints address ADMET endpoints. A quantum-inspired Hamiltonian feature set reports solubility MAE matching top TDC AqSolDB entries with 58-fold fewer interaction features. PredHLM applies XGBoost to RDKit 2D descriptors with SHAP analysis for human liver microsome half-life across 11,790 compounds. BBBP-Atlas uses a structure-aware graph model for blood-brain barrier permeability across small molecules and peptides. Published work extends this to target-directed screening, where SVM QSAR classifiers trained on ChEMBL prioritize MAO-B/Sig-1R dual ligands before docking and 150 ns MD. MGVS couples structure-based generation with chemical similarity search for synthesizable analogues, and a benchmark evaluates 2D similarity metrics for retrieval from make-on-demand spaces. What is new is the emphasis on interpretability, compact feature sets and discovery-relevant evaluation.
Published papers
Quantum Pharmacophore-Based Virtual Screening Enables Prospective Discovery of Chemotype-Diverse Dengue NS5 Inhibitors.
Introduces a quantum-derived topological pharmacophore method (DFT and QTAIM) for virtual screening; prospectively screened 43.8M compounds against dengue NS5…
Strategies for Identifying Molecules of Interest in Large Chemical Spaces.
Benchmarks 2D similarity search metrics for retrieving analogs from make-on-demand chemical spaces using about 3000 drug-relevant queries.
Prioritising search for virtual screening via preliminary interpretable low-feature likelihood-based rankings of drug-target activity measures.
Offline/online likelihood-based method ranks ligand chemical-space classes for virtual screening prioritisation, cutting docking needs versus unguided…
Topic history
| Date | Rank |
|---|---|
| #21 | |
| #21 | |
| #14 | |
| #20 | |
| #4 | |
| #13 | |
| #30 | |
| #28 | |
| #35 | |
| #33 | |
| #19 | |
| #39 | |
| #21 | |
| #15 | |
| #7 | |
| #21 | |
| #26 | |
| #10 | |
| #33 | |
| #28 | |
| #31 | |
| #6 | |
| #9 | |
| #3 | |
| #14 | |
| #14 | |
| #25 | |
| #7 | |
| #29 | |
| #25 | |
| #14 | |
| #6 | |
| #16 | |
| #9 | |
| #6 | |
| #2 | |
| #5 | |
| #5 | |
| #5 | |
| #6 | |
| #11 | |
| #39 | |
| #38 |